π
|
A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study.
90 auth.
A. Siderowf,
M. Stern,
I. Shoulson,
K. Kieburtz,
D. Oakes,
D. Day,
A. Shinaman,
S. Plumb,
S. Fahn,
K. Blindauer,
M. Lew,
H. Hurtig,
M. Lloyd,
R. Hauser,
L. Gauger,
...
L. Golbe,
J. Wojcieszek,
J. Belden,
A. Feigin,
M. Klimek,
Barbara Shannon,
W. Ondo,
C. Hunter,
V. Calabrese,
P. Atchison,
C. Allen,
F. Marshall,
Debra Berry,
I. Gardiner,
J. Miyasaki,
Luisa Del Rizzo,
T. Mendis,
Neila Mendis,
P. Gray,
J. Hubble,
Karen Betcher,
R. Pahwa,
E. Molho,
Diane L. Brown,
L. Shulman,
A. Rajput,
Marianne Ewanishin,
M. Stacy,
Kelli Williamson,
J. Bertoni,
C. Peterson,
P. Tuite,
B. Ebbitt,
K. Shannon,
J. Jaglin,
C. Tanner,
K. Marek,
Karen Stavris,
M. Aminoff,
M. Diminno,
G. Dowling,
U. Kang,
J. Richman,
K. Sethi,
W. Martin,
Pamela King,
G. McInnes,
C. Adler,
P. LeWitt,
M. DeAngelis,
M. Schear,
M. Gordon,
Roberta Winnick,
R. Feldman,
Cathi A Thomas,
K. Conn,
A. Brocht,
C. Chadwick,
Jeannette Connolly,
S. Daigneault,
S. Eberly,
J. Bausch,
L. Josephson,
R. Oliva,
S. Schwid,
A. Lang,
C. Cox,
C. Irvine,
J. Nutt,
W. White,
S. Oren,
R. Levy,
E. Eyal,
D. Ladkani,
W. Houck
|
9 |
2002 |
9 π
|
π
|
Are Ambient Ultrafine, Accumulation Mode, and Fine Particles Associated with Adverse Cardiac Responses in Patients Undergoing Cardiac Rehabilitation?
12 auth.
D. Rich,
W. Zareba,
W. Beckett,
P. Hopke,
D. Oakes,
M. Frampton,
...
J. Bisognano,
David C. Chalupa,
J. Bausch,
K. O'Shea,
Yungang Wang,
M. Utell
|
6 |
2012 |
6 π
|
π
|
Inhalation of ultrafine carbon particles alters heart rate and heart rate variability in people with type 2 diabetes
10 auth.
Rathin Vora,
W. Zareba,
M. Utell,
A. Pietropaoli,
David C. Chalupa,
Erika L. Little,
...
D. Oakes,
J. Bausch,
Jelani Wiltshire,
M. Frampton
|
5 |
2014 |
5 π
|
π
|
Fear of health insurance loss among individuals at risk for Huntington disease
8 auth.
E. Oster,
E. Dorsey,
J. Bausch,
A. Shinaman,
E. Kayson,
D. Oakes,
...
I. Shoulson,
K. Quaid
|
5 |
2008 |
5 π
|
π
|
Effects of outdoor air pollutants on platelet activation in people with type 2 diabetes
8 auth.
M. Frampton,
J. Bausch,
D. Chalupa,
P. Hopke,
Erika L. Little,
D. Oakes,
...
J. Stewart,
M. Utell
|
5 |
2012 |
5 π
|
π
|
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
8 auth.
S. Schwid,
J. Bausch,
D. Oakes,
L. Schuchter,
C. Tanner,
Misser Forrest,
...
A. Lang,
I. Shoulson
|
4 |
2010 |
4 π
|
π¬
|
Inβhospital mortality among women undergoing contemporary elective percutaneous coronary intervention: A reexamination of the gender gap
C. Narins,
F. Ling,
Michael C Fischi,
Derick R. Peterson,
J. Bausch,
W. Zareba
|
4 |
2006 |
4 π¬
|
π
|
Inaugural Huntington Disease Clinical Research Symposium Organized by the Huntington Study Group
167 auth.
K. Moser,
K. Biglan,
C. A. Ross,
D. Langbehn,
E. Aylward,
J. Stout,
S. Queller,
N. Carlozzi,
K. Duff,
L. Beglinger,
J. Paulsen,
A. Tomusk,
S. Lifer,
S. Hastings,
J. Dawson,
...
B. Walker,
K. Whitlock,
S. Johnson,
R. Pacifici,
S. Hersch,
E. Dorsey,
R. Katz,
T. Tempkin,
V. Wheelock,
G. Schwartz,
J. Corey-Bloom,
P. Mattis,
A. Feigin,
P. Young,
D. McArthur,
S. Perlman,
C. Higginson,
L. Carr,
K. Sigvardt,
M. C. Chirieac,
A. Shinaman,
I. Shoulson,
A. E. Kane,
G. Peavy,
J. Goldstein,
M. Jacobson,
S. Lessig,
L. Wasserman,
E. Kayson,
C. Tang,
D. Zgaljardic,
Y. Ma,
V. Dhawan,
M. Guttman,
D. Eidelberg,
S. Peng,
P. Kingsley,
H. Rosas,
S. Gevorkian,
D. Oakes,
W. Matson,
T. Massood,
J. Latourelle,
J. Mysore,
E. Fossale,
T. Gillis,
J. Gusella,
M. Macdonald,
R. Myers,
O. Yastrubetskaya,
J. Preston,
E. Chiu,
A. Goh,
E. Oster,
J. Bausch,
E. Kayson,
K. Quaid,
S. Sims,
M. Swenson,
J. Harrison,
C. Moskowitz,
N. Stepanov,
G. Suter,
B. Westphal,
S. A. Johnson,
D. Langbehn,
J. Paulsen,
P. Nopoulos,
L. Beglinger,
H. Johnson,
V. Magnotta,
R. Pierson,
H. Lipe,
T. Bird,
E. McCusker,
A. Lownie,
A. Lechich,
S. Montas,
A. Duckett,
J. Klager,
S. Sandler,
A. Pae,
B. Apostol,
D. Simmons,
C. Zuccato,
K. Illes,
J. Pallos,
M. Casale,
S. Kathuria,
E. Cattaneo,
J. L. Marsh,
L. Thompson,
H. Patzke,
R. Chesworth,
Z. Li,
G. Rahil,
J. Wang,
J. Smith,
F. Huet,
G. Shapiro,
S. Leit,
P. Beaulieu,
F. Raeppel,
M. Fournel,
H. Sainte-Croix,
S. Nolan,
F. Albayya,
A. Barbier,
J. Besterman,
M. Ahlijanian,
R. DΓ©ziel,
A. Aubeeluck,
H. Buchanan,
C. Ross,
K. Biglan,
B. Landwehrmeyer,
K. Whitlock,
N. Carlozzi,
L. Mickes,
J. Lee,
R. Y. Kim,
B. Toro,
E. Fine,
T. Cahill,
D. Johnson,
J. Goldstein,
G. Peavy,
M. Jacobson,
L. Goodman,
P. Como,
J. Cha,
C. Beck,
M. Adams,
G. Chadwick,
E. A. Blieck,
C. McCallum,
L. Deuel,
A. Clarke,
R. Stewart,
W. Adams,
H. Paulson,
J. Fiedorowicz,
J. M. Hanson,
N. Ramza,
J. Priller,
D. Ecker,
P. I. O. T. H. S. Group,
H. Investigators,
H. Investigators,
P. I. O. T. H. S. Group,
H. Investigators,
Ehdn Working Group βSymptomatic Treatment.β
|
1 |
2011 |
1 π
|
π
|
Influence of Insurance on the Decision to Pursue Genetic Testing in Individuals at Risk for Huntingtonβs Disease
8 auth.
E. Oster,
E. Dorsey,
J. Bausch,
A. Shinaman,
E. Kayson,
D. Oakes,
...
I. Shoulson,
K. Quaid
|
1 |
2008 |
1 π
|